Cumberland Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-97,281
Closed -$12.2M 189
2021
Q3
$12.2M Buy
97,281
+12,040
+14% +$1.56M 1% 31
2021
Q2
$10.6M Sell
85,241
-2,532
-3% -$318K 0.83% 36
2021
Q1
$10.4M Sell
87,773
-2,934
-3% -$344K 0.85% 37
2020
Q4
$10.6M Sell
90,707
-977
-1% -$108K 0.95% 32
2020
Q3
$9.53M Sell
91,684
-5,474
-6% -$550K 1% 29
2020
Q2
$8.91M Sell
97,158
-52,087
-35% -$4.99M 0.92% 36
2020
Q1
$13.5M Sell
149,245
-6,088
-4% -$648K 1.62% 23
2019
Q4
$17.6M Sell
155,333
-5,800
-4% -$636K 1.56% 23
2019
Q3
$17.5M Sell
161,133
-33,455
-17% -$3.49M 1.68% 22
2019
Q2
$19M Buy
194,588
+81,015
+71% +$7.4M 1.82% 17
2019
Q1
$10.3M Buy
113,573
+74,285
+189% +$6.65M 1.04% 32
2018
Q4
$3.57M Buy
39,288
+2,500
+7% +$234K 0.4% 52
2018
Q3
$3.62M Hold
36,788
0.35% 57
2018
Q2
$3.15M Buy
+36,788
New +$3.07M 0.32% 63

Other funds holding MDT

Cumberland Partners's MDT Position: Q4 2021 in Review

Cumberland Partners sold out of Medtronic (MDT) in Q4 2021, closing a stake of 97,281 shares — an estimated $12.2M sold.

Cumberland Partners first reported a position in MDT in Q2 2018 and held it in 14 quarters. The position peaked at $19M in Q2 2019. 2,060 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Cumberland Partners reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Cumberland Partners sold 97,281 Medtronic shares in Q4 2021, an estimated $12.2M.
  • Cumberland Partners first reported a position in Medtronic in Q2 2018 and held it in 14 quarters.
  • Cumberland Partners's Medtronic position peaked at $19M in Q2 2019.
  • 2,060 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Cumberland Partners's 13F filing for Q4 2021, filed 10 Feb 2022.